Upregulation of BMAL1 can alleviate oxidative stress and inflammation and attenuate ICH-induced brain edema through increasing Nrf2 expression and activating the Nrf2 signaling pathway (Gong et al., 2021). The gene discussed is NFE2L2; the disease is brain edema.